Medications for Gastric Adenocarcinoma

5 results

  • cyramza - ramucirumab solution

    (Ramucirumab)
    Eli Lilly And Company
    Cyramza is a VEGFR2 antagonist for treatment of adults with advanced or metastatic gastric or gastro-esophageal junction adenocarcinoma, metastatic non-small cell lung cancer, metastatic colorectal cancer, and hepatocellular carcinoma with alpha fetoprotein of 400 ng/mL or higher after sorafenib.
    Medication Details
    Drug Interactions

  • herceptin - trastuzumab injection, powder, lyophilized, for solution

    (Trastuzumab)
    Genentech, Inc.
    Herceptin treats HER2-overexpressing breast cancer, both adjuvant and metastatic, and HER2-overexpressing metastatic gastric or gastroesophageal junction adenocarcinoma in adults. Patient selection requires an FDA-authorized companion diagnostic.
    Medication Details
    Drug Interactions

  • lonsurf - trifluridine and tipiracil tablet, film coated

    (Trifluridine And Tipiracil)
    Taiho Pharmaceutical Co., Ltd.
    Lonsurf treats adults with previously treated metastatic colorectal cancer (alone or with bevacizumab) and metastatic gastric or gastroesophageal junction adenocarcinoma, after prior chemotherapy regimens including fluoropyrimidines, platinum, and irinotecan or taxane.
    Medication Details
    Drug Interactions

  • trazimera - trastuzumab - qyyp

    (Trastuzumab-Qyyp)
    Pfizer Laboratories Div Pfizer Inc
    Trazimera treats HER2-overexpressing breast cancer in adults, including adjuvant node-positive or high-risk node-negative disease, first-line metastatic breast cancer (with paclitaxel), and single-agent use after prior chemotherapy. Also indicated for HER2-overexpressing metastatic gastric or gastroesophageal junction adenocarcinoma with cisplatin and capecitabine or 5-fluorouracil.
    Medication Details
    Savings Programs
    1